GB/T 39367.1-2020

Abolished

In vitro diagnostic test systems—Qualitative nucleic acid-based in vitro examination procedures for detection and identification of microbial pathogens—Part 1: General requirements, terms and definitions

体外诊断检验系统 病原微生物检测和鉴定用核酸定性体外检验程序 第1部分:通用要求、术语和定义

Standard Type
GBT
ICS
01.040.19
CCS
C30
Status
Abolished
Issue Date
2020-11-19
Implementation
2022-06-01
Centralized Committee
国家药监局
Issuing Authority
国家市场监督管理总局、中国国家标准化管理委员会

Application Summary AI generated

This standard establishes general requirements, terms, and definitions for qualitative nucleic acid-based in vitro diagnostic procedures used to detect and identify microbial pathogens. It applies to the development, validation, and quality control of molecular diagnostic tests, such as PCR-based assays, used in clinical laboratories and medical device manufacturing. The standard ensures consistency and reliability in testing for infectious diseases across healthcare settings.

Related Standards

Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.